Verax Gains FDA Clearance for the Rapid Detection of Bacterial Contaminants in Platelets Intended for Transfusion
Verax Biomedical today announced that the company has gained FDA clearance to expand the use of its …
Verax Biomedical today announced that the company has gained FDA clearance to expand the use of its …
In the wake of receiving a CLIA waiver for its rapid, point-of-care PCR testing device, Roche execut…
Micro Imaging Technology, Inc. (MIT) announced the result of a blind study conducted with its MIT 10…
Meridian Bioscience, Inc. announced that it has received the CE Mark for new molecular assays for th…
POCARED Diagnostics, a leading in-vitro diagnostic and pre-analytical technologies manufacturer anno…
Researchers have discovered a pattern in 11 genes that could make it quick and easy to diagnose seps…
IDEXX Laboratories, Inc. announced that the company has developed, validated and made available a ne…
Vivione Biosciences Inc. ("Vivione" or the "Company") (VBI), is pleased to annou…
Vivione Biosciences Inc., announced today the execution of an Option Agreement with the University o…
PositiveID Corporation, a developer of biological detection and diagnostics solutions, today announc…
A UC Irvine research team will receive up to $5 million to further develop a bloodstream infection d…